CompletedPhase 2NCT00782288

Phase II Study of Digitoxin to Treat Cystic Fibrosis

Studying Cystic fibrosis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
National Jewish Health
Principal Investigator
Pamela L Zeitlin, MD, PhD
Johns Hopkins University, School of Medicine, Pediatric Pulmonary
Intervention
digitoxin(drug)
Enrollment
24 enrolled
Eligibility
18-45 years · All sexes
Timeline
2010 – 2016

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00782288 on ClinicalTrials.gov

Other trials for Cystic fibrosis

Additional recruiting or active studies for the same condition.

See all trials for Cystic fibrosis →

← Back to all trials